Company name
Curatis
Company profile
Curatis is a Swiss specialty pharmaceutical company focused on acquiring, developing and commercialising innovative medicines for rare and specialty diseases. The company operates a strong Swiss distribution business with exclusive rights for over 40 products and a development pipeline led by the phase 3 asset corticorelin for peritumoral brain edema.
Date, time and room information
Tuesday, May 5, 14:30 - 14:45, room Montreal
Category
Commercial stage company
Title of the presentation
Curatis fast growing commercial base with a phase III breakthrough therapy
Speaker information
| Name | Position | Institution |
|---|---|---|
| Roland Rutschmann | CEO |
